{
 "PrintNo":"S333","Session":2019,"Chamber":"SENATE","BillType":"Senate","Published":"2019-01-03T12:07:53.855086Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2020-01-08","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2019-01-09","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2020-01-08","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":913,"Name":"Fredrick J. Akshar II","Short":"AKSHAR"}],
 "Title":"Provides that coverage for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization",
 "Summary":"Provides that coverage for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to providing that coverage for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization",
 "PreviousVersions":["S8064-2017"]
}